(Q78023972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

D M Kemp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S E George

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P J Bungay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L H Naylor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

215-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of the use of the luciferase-reporter-gene system for gene-regulation studies involving cyclic AMP-elevating agents

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional partial agonism at cloned human muscarinic acetylcholine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

On serotonin and migraine: a clinical and pharmacological review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional coupling of endogenous serotonin (5-HT1B) and calcitonin (C1a) receptors in CHO cells to a cyclic AMP-responsive luciferase reporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional analysis of the D2L dopamine receptor expressed in a cAMP-responsive luciferase reporter cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Serotonin receptors: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Receptor crosstalk: communication through cell signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Partial agonists, full agonists, antagonists: dilemmas of definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Forskolin-induced up-regulation and functional supersensitivity of dopamine D2long receptors expressed by Ltk- cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Differentiation between partial agonists and neutral 5-HT1B antagonists by chemical modulation of 3-[3-(N,N-dimethylamino)propyl]-4-hydroxy- N-[4-(pyridin-4-yl)phenyl]benzamide (GR-55562)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Clinical applications of zolmitriptan (Zomig, 311C90).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Dopamine receptors: from structure to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Transcriptional regulation by cyclic AMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Dopamine receptor agonists, partial agonists and psychostimulant addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Lower efficacy: interaction with an inhibitory receptor or partial agonism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900292-7

10.1016/S0014-2999(99)00292-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10414442%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference